Trial intelligence / Profile preview

Long-term iron chelation in the prevention of secondary remote degeneration after stroke

2024-514230-20-00Phase 2Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of deferiprone in stroke (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Aug 2024; status: completed.

02

Drugs

deferiprone
03

Conditions

stroke

Beyond the preview

Go deeper on 2024-514230-20-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-514230-20-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call